These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31401731)

  • 21. PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
    Bobbitt L; Merriman E; Raynes J; Henderson R; Blacklock H; Chunilal S
    Thromb Res; 2011 Dec; 128(6):577-82. PubMed ID: 21621251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.
    Refaai MA; Goldstein JN; Lee ML; Durn BL; Milling TJ; Sarode R
    Transfusion; 2015 Nov; 55(11):2722-9. PubMed ID: 26135740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
    Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
    Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.
    Müller M; Eastline J; Nagler M; Exadaktylos AK; Sauter TC
    Scand J Trauma Resusc Emerg Med; 2019 Apr; 27(1):48. PubMed ID: 31014373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
    Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
    Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.
    Imberti D; Magnacavallo A; Dentali F; Condoleo E; Gallerani M; Benedetti R; Ageno W
    J Thromb Thrombolysis; 2013 Jul; 36(1):102-8. PubMed ID: 23054464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
    Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
    Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
    Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T
    Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials.
    Milling TJ; Refaai MA; Sarode R; Lewis B; Mangione A; Durn BL; Harman A; Lee ML; Goldstein JN
    Acad Emerg Med; 2016 Apr; 23(4):466-75. PubMed ID: 26822172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of international normalised ratio in major bleeding related to vitamin K antagonists is associated with better survival: A UK study.
    Tan J; MacCallum P; Curry N; Stanworth S; Tait C; Morris JK; Green L
    Thromb Res; 2021 Jan; 197():153-159. PubMed ID: 33220564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current evidence of oral anticoagulant reversal: A systematic review.
    Tornkvist M; Smith JG; Labaf A
    Thromb Res; 2018 Feb; 162():22-31. PubMed ID: 29258056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis.
    Puchstein D; Kork F; Schöchl H; Rayatdoost F; Grottke O
    Thromb Haemost; 2023 Jan; 123(1):40-53. PubMed ID: 36626899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urgent reversal of vitamin K antagonist therapy.
    Vang ML; Hvas AM; Ravn HB
    Acta Anaesthesiol Scand; 2011 May; 55(5):507-16. PubMed ID: 21418150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage.
    Laible M; Jenetzky E; Beynon C; Müller OJ; Sander P; Schüler S; Purrucker J; Möhlenbruch M; Steiner T; Veltkamp R; Ringleb PA; Rizos T
    Cerebrovasc Dis; 2016; 42(5-6):446-454. PubMed ID: 27536779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: a retrospective, single center study.
    Leal-Noval SR; López-Irizo R; Bautista-Paloma J; Casado M; Arellano-Orden V; Leal-Romero M; Fernández-Hinojosa E; Puppo-Moreno A; Muñoz M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):862-8. PubMed ID: 24060736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
    Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
    Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.